Ignite Creation Date:
2024-05-06 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 2:15 PM
Study NCT ID:
NCT05082259
Status:
RECRUITING
Last Update Posted:
2023-08-22
First Post:
2021-10-06
Brief Title:
ASTEROID A Trial of ASTX660 in Combination With Pembrolizumab
Sponsor:
Institute of Cancer Research United Kingdom
Organization:
Institute of Cancer Research United Kingdom
Organization Data
Organization:
Institute of Cancer Research United Kingdom
Class:
OTHER
Study ID:
CCR5199
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institute of Cancer Research United Kingdom
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Cancer Research UK | OTHER |
| Astex Pharmaceuticals Inc | INDUSTRY |
| Merck Sharp Dohme LLC | INDUSTRY |